Phase I Pharmacokinetic Study (SALBLOCK)
clinical trial
Press Enter · cited answer in seconds
0 sources
Phase I Pharmacokinetic Study (SALBLOCK)
Summary
Phase I Pharmacokinetic Study (SALBLOCK) is a clinical trial[1].
Key Facts
- Phase I Pharmacokinetic Study (SALBLOCK) is in the country of Finland[2].
- Phase I Pharmacokinetic Study (SALBLOCK)'s instance of is recorded as clinical trial[3].
- Phase I Pharmacokinetic Study (SALBLOCK)'s start time is recorded as +2012-04-30T00:00:00Z[4].
- Phase I Pharmacokinetic Study (SALBLOCK)'s end time is recorded as +2012-06-30T00:00:00Z[5].
- Phase I Pharmacokinetic Study (SALBLOCK)'s number of participants is recorded as {'unit': '1', 'amount': '+20'}[6].
- Phase I Pharmacokinetic Study (SALBLOCK)'s title is recorded as Effect of Charcoal on Gastrointestinal Absorption of Salmeterol and Fluticasone Propionate.[7].
- Phase I Pharmacokinetic Study (SALBLOCK)'s short name is recorded as SALBLOCK[8].
- Phase I Pharmacokinetic Study (SALBLOCK)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[9].
- Phase I Pharmacokinetic Study (SALBLOCK)'s ClinicalTrials.gov ID is recorded as NCT01564199[10].
- Phase I Pharmacokinetic Study (SALBLOCK)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}[11].
- Phase I Pharmacokinetic Study (SALBLOCK)'s research intervention is recorded as fluticasone[12].
- Phase I Pharmacokinetic Study (SALBLOCK)'s research intervention is recorded as salmeterol xinafoate[13].
- Phase I Pharmacokinetic Study (SALBLOCK)'s clinical trial phase is recorded as phase I clinical trial[14].
- Phase I Pharmacokinetic Study (SALBLOCK)'s research site is recorded as Cardiopulmonary Research Science and Technology Institute[15].
- Phase I Pharmacokinetic Study (SALBLOCK)'s research subject recruitment status is recorded as completed[16].
- Phase I Pharmacokinetic Study (SALBLOCK)'s study type is recorded as interventional study[17].